indacrinone has been researched along with Shock, Septic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chanda, D; Darokar, MP; Dwivedi, GR; Kumar, A; Negi, AS; Pal, A; Roy, S; Sharma, A; Singh, A; Tiwari, N | 1 |
1 other study(ies) available for indacrinone and Shock, Septic
Article | Year |
---|---|
Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Escherichia coli; Gallic Acid; Indans; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Shock, Septic; Tetracycline | 2016 |